Skip to main content

Instil Bio, Inc.

TIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001789769

No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $29.2M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Instil Bio, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of TIL: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders7973−6
Shares101.7M92.1M−9.57M (−9.4%)
Value$64.1M$60.9M−$3.19M (−5.0%)

New holders (8)

Institutions that held Instil Bio, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to TIL in Q1 2023
InstitutionSharesValue% of portfolio
Western Standard LLC1,796,987$1.19M1.20%
Tang Capital Management LLC200,000$132.2K0.02%
Assenagon Asset Management S.A.139,280$92.0K0.00%
Wells Fargo & Company12,322$8.14K0.00%
Bank of Montreal11,376$7.64K0.00%
Sawtooth Solutions, LLC11,054$7.30K0.00%
Bleakley Financial Group, LLC11,054$7.30K0.00%
Baker Avenue Asset Management, LP4,000$2.64K0.00%

Sold out (14)

Institutions that held Instil Bio, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.